BIOX
Bioceres Crop Solutions Corp.
$1.67
-$0.10(-5.65%)
47
Overall
--
Value
50
Tech
44
Quality
Market Cap
$120.04M
Volume
524.13K
52W Range
$1.66 - $8.27
Target Price
$4.17
Order:
Income Statement
| Metric | Trend | Chart | 2019 Jun | 2020 Jun | 2021 Jun | 2022 Jun | 2023 Jun | 2024 Jun |
|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||
| Total Revenue | $158.9M | $172.4M | $206.7M | $43.3M | $419.4M | $464.8M | ||
| Total Revenue | $160.6M | $173.1M | $209.5M | $43.3M | $419.4M | $464.8M | ||
| COST OF GOODS SOLD | ||||||||
| Cost of Revenue | $-87.0M | $-93.6M | $-118.6M | $10.2M | $235.5M | $278.2M | ||
| GROSS PROFIT | ||||||||
| Gross Profit | $71.9M | $78.8M | $88.1M | $33.2M | $184.0M | $186.6M | ||
| OPERATING EXPENSES | ||||||||
| Operating Expenses | $42.9M | $42.5M | $74.5M | $26.7M | $126.2M | $139.3M | ||
| Research & Development | $3.7M | $4.2M | $5.6M | $-6.9M | $3.9M | $3.8M | ||
| Research Expense | $3.7M | $4.2M | $5.6M | -- | $3.9M | $3.8M | ||
| Selling, General & Administrative | $39.2M | $38.3M | $68.8M | $20.6M | $33.2M | $38.1M | ||
| Selling & Marketing Expenses | $39.2M | $38.3M | $47.6M | $20.6M | $11.7M | $13.5M | ||
| General & Administrative Expenses | $-19.2M | $-17.6M | $21.2M | $-32.5M | $21.5M | $24.6M | ||
| Promotion & Advertising | $-1.7M | $-1.7M | $-2.5M | $-4.8M | $5.7M | $5.0M | ||
| Salaries & Wages | $-20.9M | -- | -- | -- | $61.0M | $66.5M | ||
| Depreciation & Amortization | $-2.2M | $-1.9M | $-2.6M | $-3.3M | $16.6M | $16.7M | ||
| Depreciation & Amortization | $-2.2M | $20.9M | $21.2M | $-3.3M | $16.6M | $16.7M | ||
| Amortization | $-1.3M | $-1.1M | $-1.3M | $-1.8M | $10.8M | $11.9M | ||
| Other Operating Expenses | $-228.2K | $-188.8K | $-365.7K | $6.1M | $11.3M | -- | ||
| OPERATING INCOME | ||||||||
| Operating income | $29.0M | $36.2M | $13.6M | $6.4M | $57.8M | $47.3M | ||
| EBITDA | $-25.9M | $-10.4M | $-907.4K | $8.8M | $36.2M | $58.2M | ||
| NON-OPERATING ITEMS | ||||||||
| Interest Expense (Non-Operating) | $-21.4M | $-21.5M | $-17.7M | $1.1M | $23.8M | $26.9M | ||
| Interest Income Operating | $-14.3M | $-3.5M | -- | -- | -- | -- | ||
| Intinc | $-41.5M | $-32.7M | $-27.9M | $32.0K | -- | -- | ||
| Net Non-Operating Interest Income/Expense | $-35.5M | $-11.8M | $-6.6M | $-1.1M | $-23.8M | $-26.9M | ||
| Gain on Sale of Securities | $11.3K | $-5.2M | $1.6M | -- | $-438.5K | $1.7M | ||
| Other Income/Expense | $-3.3M | $-1.7M | $-8.5M | $92.0K | $8.4M | $13.0M | ||
| Other Special Charges | $16.4K | $3.9M | $2.3K | $-92.0K | $-1.9M | $-3.3M | ||
| SPECIAL ITEMS | ||||||||
| Restructring And Mn A Income | $24.4M | -- | -- | -- | -- | -- | ||
| Special Income Charges | $365.9K | $-20.9M | $560.9K | $1.6M | $-1.3M | $-753.4K | ||
| Impairment of Capital Assets | $-687.0K | $-1.5M | $-560.9K | $-1.6M | $1.3M | $753.4K | ||
| PRE-TAX INCOME | ||||||||
| EBIT | $-30.8M | $-15.1M | $-7.2M | $6.4M | $16.8M | $36.9M | ||
| Pre-Tax Income | $-9.4M | $6.4M | $10.5M | $5.3M | $-6.9M | $10.0M | ||
| INCOME TAX | ||||||||
| Tax Provision | $7.0M | $2.2M | $14.4M | $-247.0K | $1.1M | $3.8M | ||
| NET INCOME | ||||||||
| Net Income | $-41.3M | $-6.7M | $14.2M | $5.5M | $-9.4M | $3.2M | ||
| Net Income (Continuing Operations) | $-41.3M | $-6.7M | $14.2M | $5.5M | $-8.0M | $6.3M | ||
| Net Income (Discontinued Operations) | $-41.3M | $-6.7M | $14.2M | $5.5M | $-9.4M | $3.2M | ||
| Net Income (Common Stockholders) | $-41.3M | $-6.7M | $14.2M | $5.5M | $-9.4M | $3.2M | ||
| Normalized Income | -- | -- | -- | -- | $-3.8M | $10.7M | ||
| TOTALS | ||||||||
| Total Expenses | $-44.0M | $-51.0M | $-44.2M | $36.9M | $361.6M | $417.5M | ||
| SHARE & EPS DATA | ||||||||
| Average Shares Outstanding | $30.5M | $36.1M | $39.2M | $182.4M | $62.1M | $62.8M | ||
| Average Shares Outstanding (Diluted) | $68.8M | $73.9M | $79.1M | $182.4M | $63.2M | $63.5M | ||
| Shares Outstanding | $36.1M | $62.8M | $41.1M | $45.9M | $62.8M | $62.8M | ||
| Basic EPS | $-0.60 | $0.09 | $-0.18 | $-0.09 | $0.30 | $0.05 | ||
| Basic EPS (Continuing Operations) | -- | -- | -- | -- | $0.30 | $0.05 | ||
| Diluted EPS | $-0.60 | $0.09 | $-0.18 | $-0.09 | $0.30 | $0.05 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | -- | $0.30 | $0.05 | ||
| OTHER METRICS | ||||||||
| Acquired In Process Rn D | $365.9K | -- | -- | -- | -- | -- | ||
| Acquired In Process Rn D Income | $365.9K | -- | -- | -- | -- | -- | ||
| Commission Expenses | $-1.6M | $-1.5M | $-2.3M | $-3.0M | $16.3K | -- | ||
| Development Expense | -- | $20.9M | -- | -- | -- | -- | ||
| Earnings from equity interest | $1.0M | $-2.7M | $997.4K | $1.1M | $1.2M | $4.0M | ||
| Earnings From Equity Interest Net Of Tax | $1.0M | $-2.7M | $997.4K | $1.1M | $1.2M | $4.0M | ||
| Gain On Sale Of Business | $-14.3M | $-222.9K | $2.7M | -- | -- | -- | ||
| Gain On Sale Of P P E | $279.9K | $716.7K | $2.4M | $6.4M | -- | -- | ||
| Insurance And Claims | $-907.7K | $-359.2K | $-1.1M | $-1.7M | $3.1M | $2.2M | ||
| Loss And Loss Adjustment Expected Incurred | $24.4M | -- | -- | -- | -- | -- | ||
| Minority Interests | $2.0M | $877.5K | $3.0M | -- | $-1.4M | $-3.0M | ||
| Other Costof Revenue | -- | -- | -- | -- | $235.5M | $278.2M | ||
| Other Gand A | $-19.2M | $-17.6M | $21.2M | $-32.5M | $21.5M | $24.6M | ||
| Other Taxes | -- | -- | -- | -- | $11.5M | $14.2M | ||
| Realized Capital Gain | $1.9M | $521.4K | $-2.3M | -- | -- | -- | ||
| Selling Expense | $39.2M | $38.3M | $47.6M | $20.6M | $93.6K | -- | ||
| Write Off | -- | $20.9M | -- | -- | -- | -- | ||
| Restruct | $24.4M | -- | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BIOX | $1.67 | -5.6% | 524.13K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Bioceres Crop Solutions Corp. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW